About Nyxoah Sa (NYXH)
Nyxoah SA develops neurostimulation devices. The Company offers tiny implantable neurostimulator for the treatment of sleep disorder breathing conditions. Nyxoah serves healthcare sectors in Belgium.
- USD10.81
- USD11.36
- USD9.92
- 22.04k
Stock News
yesterday
Cramer praises companies like Chipotle that can grow despite a slowing economy and inflation
CNBC
yesterday
Bristol Myers Squibb stock tumbles on cost-cutting initiative
Yahoo
yesterday
Alphabet stock pops off on Q1 earnings beat, cash dividend
Yahoo
yesterday
H&R Block to Release Fiscal 2024 Third Quarter Results on May 9, 2024
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
